Jeremy Hayllar
Dados Biográficos
| ID | 5574094 |
|---|---|
| NOME | Jeremy Hayllar |
| PRENOMES | Jeremy |
| SOBRENOME | Hayllar |
| ASSINATURA | HAYLLAR J |
| AFILIAÇÕES | Metro South Health |
| ORCID | 0000-0003-3065-7591 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 8 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 8 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2018 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
You'll come in and dose even in a global pandemic”
Rigidity in the delivery of OAT has been an impediment to achieving health and wellbeing over past decades. To sustain health-promoting environments for people receiving OAT, the wider impacts of the complex system should be acknowledged beyond narrowly defined outcomes relating solely to the medication. Centring people receiving OAT in their own care plans will ensure adaptations in the complex system of OAT provision are responsive to the indiv…
I just thought that was the best thing for me to do at this point’
Depot buprenorphine remains a promising treatment for OUD and offers potential to improve treatment adherence. Instances of restricted OAT choice and consumer concerns regarding a lack of agency must be addressed in order to enhance therapeutic relationships. Clinicians and other healthcare workers in this field also need greater access to information about depot buprenorphine to better address issues patients face during treatment. More research…
Kamini, a little recognised source of illicit opioid
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia
Sem obras proeminentes nesta página.
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Kamini, a little recognised source of illicit opioid
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
You'll come in and dose even in a global pandemic”
Rigidity in the delivery of OAT has been an impediment to achieving health and wellbeing over past decades. To sustain health-promoting environments for people receiving OAT, the wider impacts of the complex system should be acknowledged beyond narrowly defined outcomes relating solely to the medication. Centring people receiving OAT in their own care plans will ensure adaptations in the complex system of OAT provision are responsive to the indiv…
I just thought that was the best thing for me to do at this point’
Depot buprenorphine remains a promising treatment for OUD and offers potential to improve treatment adherence. Instances of restricted OAT choice and consumer concerns regarding a lack of agency must be addressed in order to enhance therapeutic relationships. Clinicians and other healthcare workers in this field also need greater access to information about depot buprenorphine to better address issues patients face during treatment. More research…
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
Medicine (7 obras) · HIV, Drug Use, Sexual Risk (5 obras) · Internal Medicine (5 obras) · Opioid (4 obras) · Opioid Use Disorder Treatment (4 obras) · Psychiatry (4 obras) · Psychology (4 obras) · Substance Abuse Treatment and Outcomes (3 obras) · Emergency Medicine (2 obras) · Family medicine (2 obras)